Lymphoma

Top Story

Radiotherapy shows potential role in treatment of Hodgkin lymphoma subtype

Radiotherapy shows potential role in treatment of Hodgkin lymphoma subtype
November 17, 2017

Radiotherapy prolonged OS among patients with all stages of nodular lymphocytic Hodgkin lymphoma, including those with B-symptoms, according to study results.

However, patients with advanced-stage disease and B-symptoms appeared unlikely to undergo radiotherapy, results also showed.

FDA News

FDA approves Gazyva for treatment-naive advanced follicular lymphoma

November 16, 2017
The FDA approved use of obinutuzumab as part of a therapeutic regimen for patients with treatment-naive advanced follicular lymphoma, according to the agent’s…
Meeting News

Gottlieb sees ‘watershed opportunity’ to shape future of FDA’s regulatory process

November 16, 2017
WASHINGTON — When diagnosed with Hodgkin lymphoma at…
FDA News

FDA authorizes IMPACT test to rapidly identify cancer mutations

November 15, 2017
The FDA today authorized Integrated Mutation Profiling of Actionable Cancer Targets, or IMPACT, an in vitro diagnostic test that uses next-generation sequencing to…
More Headlines »
CME

Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?

This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.

It is estimated that 76,380 new cases of melanoma will be diagnosed in the United Stated in 2017, with approximately…
More »
Video
Meeting News

VIDEO: Combination regimen ‘viable, effective’ for follicular lymphoma

June 14, 2017
More »
Resource Centers

CME

What's Hot in Melanoma? Highlights from the HemOnc Today Melanoma and Cutaneous Malignancies 2017 Meeting

This activity is supported by an educational grant from Merck & Co, Inc.

The development and integration of targeted therapies, as well as immunotherapies, into clinical strategies for the…
More »